REGENERON PHARMACEUT

REGN
Delayed Quote. Delayed  - 09/25 04:00:00 pm
574.06USD +2.98%
Prev.557.4600
Open555.4000
High575.9150
Low551.0000
Volume643 630
Latest news
5d ago
09/18
09/17
09/15
Chart REGENERON PHARMACEUTICALS
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralBullish
Resistance580658644
Spread/Res.-1,1%-13%-11%
Spread/Supp.5,4%16%31%
Support545493438
Financials
Sales 2020 8 400 M - -
Net income 2020 2 993 M - -
Net cash 2020 4 572 M - -
P/E ratio 2020 20,7x
Yield 2020 -
Capitalization 60 409 M 60 409 M -
EV / Sales 2020 6,65x
EV / Sales 2021 5,40x
Nbr of Employees 8 142
Free-Float 83,3%
Company
Regeneron Pharmaceuticals specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Sales break down by activity as follows:
- sales of products (61.5%);
- supply of collaborative services (33.3%): working with Sanofi...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2020-11-04 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 668,04 $
Last Close Price 574,06 $
Spread / Highest target 39,4%
Spread / Average Target 16,4%
Spread / Lowest Target -12,9%